Mutation analysis of the ECE1 gene in late-onset Alzheimer's disease

Neurobiol Aging. 2023 Sep:129:58-61. doi: 10.1016/j.neurobiolaging.2023.05.002. Epub 2023 May 9.

Abstract

We recently identified a rare coding mutation (R186C) in the ECE2 gene in a late-onset AD (LOAD) family, and demonstrated ECE2 is a risk gene for AD development. ECE1 is a homologous enzyme that shares catalytic activity with ECE2. Although ECE1 has been regarded as a potential candidate gene for AD, few studies have investigated the role of ECE1 variants in patients with AD. In this study, we aimed to investigate rare variants in ECE1 in a cohort of 610 patients with LOAD (age of onset ≥65 years). The summary data of ECE1 variants from ChinaMAP database were used as controls (n = 10,588). We found four rare variants (p.R50W, p.A166=, p.R650Q, and p.P751=) in the patients with sporadic LOAD, while we identified a large number of controls carrying rare variants in ECE1. Moreover, there was no significant association between LOAD and non-synonymous rare damaging variants at the gene level. Our results suggest rare coding variants of ECE1 might not play an important role in AD risk in the Chinese population.

Keywords: Alzheimer’s disease; ECE1; Rare variants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease* / genetics
  • Endothelin-Converting Enzymes / genetics
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Mutation

Substances

  • ECE1 protein, human
  • Endothelin-Converting Enzymes